Hereditary nonpolyposis colorectal cancer syndrome, also known as Lynch syndrome, is a genetic condition that significantly increases the risk of developing colorectal cancer and several other types of cancer, often at a younger age than typically seen in the general population.
Understanding Hereditary Nonpolyposis Colorectal Cancer
Hereditary nonpolyposis colorectal cancer, often called HNPCC, is a type of cancer that runs in families due to changes in specific genes that are passed down from parents to children. This condition is closely related to Lynch syndrome, which is the underlying genetic disorder that causes HNPCC. When someone inherits certain genetic mutations from their biological parents, they develop what is called a family cancer syndrome, which is a genetic disorder associated with a higher risk of developing certain cancers.[1]
The relationship between HNPCC and Lynch syndrome can sometimes be confusing. HNPCC typically refers to people or families who have Lynch syndrome-associated cancer diagnosed before the age of 50. This can include colorectal cancer as well as cancers of the endometrium, small bowel, ureter, and renal pelvis. Meanwhile, Lynch syndrome is the term used when healthcare professionals identify the specific gene mutation that runs in the family and causes these cancers.[3]
When someone has HNPCC, the cancer typically develops on the right side of the colon, which is different from where most sporadic colorectal cancers occur. This distinctive location can be an important clue for doctors when evaluating a patient’s condition and determining whether genetic testing might be appropriate.[1]
Epidemiology: How Common Is HNPCC?
Between 2 and 4 percent of all colorectal cancers are caused by HNPCC, making it a relatively uncommon but significant form of this disease. Although it represents a small percentage of all colorectal cancer cases, identifying people with HNPCC is crucial because their lifetime risk of developing cancer is substantially higher than that of the general population.[1]
In the United States, it is estimated that approximately 1 in 279 individuals carry a genetic variant associated with Lynch syndrome. This makes Lynch syndrome the most common hereditary colorectal cancer syndrome, accounting for the majority of inherited colorectal cancer cases. While most colorectal cancers are sporadic, meaning they occur by chance rather than due to inherited mutations, about 5 to 10 percent of cases are caused by inherited genetic changes.[4][2]
Anyone can develop HNPCC regardless of their background or ethnicity. However, most people with this condition receive their diagnosis before reaching age 50, which is younger than the typical age for sporadic colorectal cancer. The mean age of colorectal cancer diagnosis in families that meet the clinical criteria for HNPCC is approximately 44 years old.[1][5]
Lynch syndrome also causes approximately 3,800 cases of colorectal cancer and 1,600 cases of uterine cancer each year in the United States. These numbers highlight the significant impact this genetic condition has on cancer incidence, even though it represents a minority of overall cancer cases.[6]
Causes: The Genetic Basis of HNPCC
HNPCC is caused by inherited mutations in specific genes that normally help protect the body from cancer. When you inherit certain gene mutations from your biological parents, you develop a family cancer syndrome. These syndromes are genetic disorders that increase the risk of developing colorectal cancers and other related malignancies.[1]
Lynch syndrome, the family cancer syndrome that causes HNPCC, develops when a person has mutations in one of several important genes. These genes include MLH1, MSH2, MSH6, PMS2, and EPCAM. These five genes are responsible for a critical process called DNA mismatch repair, which means they help correct mistakes that naturally occur when cells copy their DNA during cell division.[1][6]
Under normal circumstances, these genes work together as a quality control system for DNA replication. They identify and fix errors that occur when DNA is copied in preparation for cell division. This repair system is essential for preventing the accumulation of genetic mistakes that can lead to cancer. However, when these genes are mutated, they cannot perform their protective function properly. As a result, cells are unable to fix DNA replication errors, leading to an increased tendency for normal cells to become cancerous.[1]
The EPCAM gene functions differently from the other mismatch repair genes. Although it is not directly involved in DNA repair, the EPCAM gene lies right next to the MSH2 gene on chromosome 2. Certain mutations in the EPCAM gene can cause the MSH2 gene to be turned off or inactivated. When this happens, the MSH2 gene cannot perform its role in DNA repair, which can also lead to the accumulation of DNA errors and eventual cancer development.[4]
Risk Factors: Who Is at Higher Risk?
The primary risk factor for HNPCC is having a family history of colorectal cancer or other Lynch syndrome-associated cancers. Because HNPCC is an inherited condition, people who have biological relatives diagnosed with these cancers, especially at a young age, are at significantly higher risk of carrying the genetic mutation themselves.[3]
Certain patterns in family health history suggest a higher risk of Lynch syndrome. These include having three family members with Lynch syndrome-related cancer, cancers occurring in two successive generations, at least two affected family members being first-degree relatives (such as parent and child or siblings), and one family member developing cancer before age 50. These criteria help doctors identify families who should be evaluated for Lynch syndrome.[15]
People with Lynch syndrome face substantially elevated lifetime risks for various cancers compared to the general population. Individuals with mutations in the MLH1 gene have a 46 percent risk of colorectal cancer and a 43 percent risk of endometrial cancer by age 75. Those with MSH2 mutations face a 57 percent colorectal cancer risk and a 17 percent endometrial cancer risk. The risks vary depending on which specific gene is mutated, with MSH6 and PMS2 mutations generally conferring lower but still elevated risks.[5]
The overall lifetime risk of developing colorectal cancer for people with Lynch syndrome ranges from 50 to 80 percent, meaning that most people with this genetic condition will develop colorectal cancer at some point in their lives if they do not take preventive measures. Women with Lynch syndrome also face a 25 to 60 percent lifetime risk of developing endometrial cancer, making this the second most common cancer associated with the syndrome.[2]
Beyond colorectal and endometrial cancer, people with Lynch syndrome have increased risks for several other types of cancer. These include ovarian cancer, gastric (stomach) cancer, small intestine cancer, urinary tract cancers affecting the kidney, ureter, and bladder, biliary tract cancers involving the liver, gallbladder, and bile ducts, pancreatic cancer, prostate cancer, brain cancer, and certain types of skin cancers. The specific risks for these other cancers vary depending on which gene is mutated.[3][6]
Symptoms: Recognizing the Warning Signs
HNPCC may not cause any symptoms in the early stages. In fact, many people with Lynch syndrome feel completely healthy until cancer develops. This is why regular screening is so important for people who know they carry the genetic mutation or have a strong family history suggesting Lynch syndrome.[1]
As colorectal cancer grows, several symptoms may develop. These include abdominal pain or bloating, which may feel uncomfortable or cause cramping sensations in the belly area. Loss of appetite is another common symptom, where people may find they do not feel hungry or food does not appeal to them as it normally would. Bloody stools are a particularly important warning sign, as blood in the stool can indicate bleeding within the digestive tract.[1]
Fatigue, or extreme tiredness that does not improve with rest, is another symptom that may develop as cancer progresses. Unexplained weight loss, where a person loses weight without trying to do so through diet or exercise changes, can also signal the presence of cancer. These symptoms can occur with other health conditions as well, which is why it is important to see a healthcare provider for proper evaluation if any of these signs develop.[1]
Two-thirds of colon cancers in people with Lynch syndrome occur in the proximal colon, which is the right side of the large intestine. Common signs and symptoms specific to this location include blood in the stool, changes in bowel habits such as diarrhea or constipation, and unintended weight loss. These symptoms may develop gradually, making it easy to overlook them initially.[5]
For women with Lynch syndrome, endometrial cancer may present with abnormal vaginal bleeding. This is the most common symptom of endometrial cancer and should always be evaluated by a healthcare provider, especially in women with a family history suggesting Lynch syndrome. In fact, among women with Lynch syndrome who develop both colon and endometrial cancer, about half are diagnosed with endometrial cancer first, making it an important sentinel cancer for the syndrome.[5]
Prevention: Reducing Cancer Risk
While it is not possible to prevent HNPCC itself, since it is an inherited genetic condition, there are several important steps people with Lynch syndrome can take to reduce their risk of developing cancer or to catch cancer at an early, more treatable stage. Regular screening and surveillance are the cornerstones of cancer prevention for people with Lynch syndrome.[2]
For people with Lynch syndrome, colonoscopy screening should begin much earlier than recommended for the general population. Healthcare providers typically recommend that colonoscopy screening start between ages 20 and 25, or 10 years younger than the youngest family member diagnosed with colorectal cancer, whichever comes first. These colonoscopies should be performed every one to two years, which is more frequent than standard screening recommendations.[2]
Women with Lynch syndrome should undergo regular screening for endometrial and ovarian cancers. This typically includes annual endometrial biopsy and transvaginal ultrasound beginning at age 30 to 35. These screening tests allow doctors to detect abnormalities early when treatment is most likely to be successful.[7]
Some people with Lynch syndrome may consider prophylactic surgery to prevent cancer from developing. For women who have completed childbearing, prophylactic hysterectomy (removal of the uterus) and bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes) can significantly reduce the risk of endometrial and ovarian cancers. These are major decisions that should be discussed carefully with healthcare providers, considering individual circumstances and preferences.[12]
Certain medications may help reduce cancer risk in people with Lynch syndrome. Some studies suggest that regular aspirin use may lower the risk of colorectal cancer. However, any medication decisions should be made in consultation with healthcare providers, who can weigh the potential benefits against possible side effects and individual health considerations.[2]
Genetic counseling and testing are important preventive tools for families affected by Lynch syndrome. If a family member has been diagnosed with Lynch syndrome, other relatives should be informed so they can consider genetic testing. Knowing one’s genetic status allows for appropriate screening and preventive measures to be implemented. Genetic counselors can help families understand their risk, interpret test results, and make informed decisions about testing and prevention.[3]
Pathophysiology: How HNPCC Affects the Body
The pathophysiology of HNPCC involves fundamental changes in how cells maintain the integrity of their genetic information. In healthy individuals, the body has sophisticated mechanisms to ensure that DNA is copied accurately when cells divide. However, mistakes inevitably occur during this copying process, and the body has evolved repair systems to fix these errors before they cause problems.[2]
The mismatch repair genes—MLH1, MSH2, MSH6, and PMS2—are responsible for identifying and correcting mistakes that happen during DNA replication. These genes work together as a quality control team, scanning newly copied DNA for errors and fixing any mismatches they find. This repair system is crucial for preventing the accumulation of genetic mutations that could lead to uncontrolled cell growth and cancer.[1]
When someone has Lynch syndrome, they inherit a mutation in one of these mismatch repair genes. This means that from birth, every cell in their body carries one defective copy of the gene. Although they still have one working copy inherited from their other parent, this situation creates vulnerability. If the remaining working copy of the gene becomes damaged or inactivated in a particular cell, that cell loses its ability to repair DNA mistakes effectively.[4]
Once both copies of a mismatch repair gene are non-functional in a cell, errors begin to accumulate in that cell’s DNA. These errors particularly affect certain repetitive sequences in the DNA called microsatellites. When the mismatch repair system is not working, these microsatellite regions become unstable and change in length, a phenomenon called microsatellite instability or MSI. The presence of MSI in tumor tissue is a hallmark of Lynch syndrome-associated cancers and can be detected through laboratory testing.[2]
As DNA errors accumulate over time, they may eventually affect genes that control cell growth and division. When enough of these critical genes become damaged, the cell may start to grow uncontrollably and develop into a tumor. This process explains why people with Lynch syndrome have such a high risk of developing cancer—their cells have a reduced ability to maintain genetic stability and prevent the accumulation of cancer-causing mutations.[1]
The specific gene that is mutated influences which cancers are most likely to develop and at what age. For example, people with MLH1 or MSH2 mutations tend to have higher cancer risks and earlier age of onset compared to those with MSH6 or PMS2 mutations. These differences in penetrance (the likelihood that a genetic mutation will actually cause disease) reflect the varying roles these genes play in DNA repair and cancer prevention.[9]
Unlike another hereditary colorectal cancer syndrome called familial adenomatous polyposis, people with Lynch syndrome typically do not develop hundreds of colon polyps. Instead, they may develop fewer polyps than would be seen in FAP, but these polyps have a much higher chance of progressing to cancer, and they tend to do so more rapidly. This is why frequent colonoscopy surveillance is so important—it allows doctors to find and remove polyps before they become cancerous.[1]
